Lennox International 10-Q 2023-09-30
LII · CIK 1069202 · Form 10-Q · Period ended September 30, 2023 · Filed October 26, 2023
8 sections, 156K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2023
OR
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _____to ______
Commission file number 001-15149
LENNOX INTERNATIONAL INC**.**
Incorporated pursuant to the laws of the State of Delaware
Internal Revenue Service Employer Identification No. 42-0991521
2140 LAKE PARK BLVD., RICHARDSON, Texas, 75080
(972) 497-5000
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common stock, $0.01 par value per share | LII | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large Accelerated Filer | ☒ | Accelerated Filer | ☐ | |||||||||||
| Non-Accelerated Filer | ☐ | Smaller Reporting Company | ☐ | |||||||||||
| Emerging growth company | ☐ | |||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of October 16, 2023, the number of shares outstanding of the registrant’s common stock, par value $0.01 per share, was 35,539,725.
LENNOX INTERNATIONAL INC.
FORM 10-Q
For the three and nine months ended September 30, 2023
INDEX
| Page | ||||||||
| Part I | Financial Information | |||||||
| Item 1. Financial Statements | ||||||||
| Consolidated Balance Sheets - September 30, 2023 (Unaudited) and December 31, 2022 | 1 | |||||||
| Consolidated Statements of Operations (Unaudited) - Three and Nine Months Ended September 30, 2023 and 2022 | 2 | |||||||
| Consolidated Statements of Comprehensive Income (Unaudited) - Three and Nine Months Ended September 30, 2023 and 2022 | 3 | |||||||
| Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - Three and Nine Months Ended September 30, 2023 and 2022 | 4 | |||||||
| Consolidated Statements of Cash Flows (Unaudited) - Nine Months Ended September 30, 2023 and 2022 | 6 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | 7 | |||||||
| Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 21 | |||||||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 31 | |||||||
| Item 4. Controls and Procedures | 31 | |||||||
| Part II | Other Information | |||||||
| Item 1. Legal Proceedings | 31 | |||||||
| Item 1A. Risk Factors | 31 | |||||||
| Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities | 31 | |||||||
| Item 5. Other Information | 31 | |||||||
| Item 6. Exhibits | 33 |
i
Part I - Financial Information
Item 1. Financial Statements
LENNOX INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Balance Sheets
| (Amounts in millions, except shares and par values) | As of September 30, 2023 | As of December 31, 2022 | |||||||||
| (Unaudited) | |||||||||||
| ASSETS | |||||||||||
| Current Assets: | |||||||||||
| Cash and cash equivalents | $ | 132.0 | $ | 52.6 | |||||||
| Short-term investments | 9.6 | 8.5 | |||||||||
| Accounts and notes receivable, net of allowances of $15.3 and $15.5 in 2023 and 2022, respectively | 694.8 | 608.5 | |||||||||
| Inventories, net | 747.9 | 753.0 | |||||||||
| Assets held for sale | 92.8 | — | |||||||||
| Other assets | 65.3 | 73.9 | |||||||||
| Total current assets | 1,742.4 | 1,496.5 | |||||||||
| Property, plant and equipment, net of accumulated depreciation of $897.5 and $920.8 in 2023 and 2022, respectively | 602.1 | 548.9 | |||||||||
| Right-of-use assets from operating leases | 214.1 | 219.9 | |||||||||
| Goodwill | 181.7 | 186.3 | |||||||||
| Deferred income taxes | 50.1 | 27.5 | |||||||||
| Other assets, net | 99.7 | 88.5 | |||||||||
| Total assets | $ | 2,890.1 | $ | 2,567.6 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||
| Current Liabilities: | |||||||||||
| Current maturities of long-term debt | $ | 361.6 | $ | 710.6 | |||||||
| Current operating lease liabilities | 60.2 | 63.3 | |||||||||
| Accounts payable | 345.8 | 427.3 | |||||||||
| Accrued expenses | 408.7 | 376.9 | |||||||||
| Liabilities held for sale | 69.7 | — | |||||||||
| Income taxes payable | 9.0 | 17.6 | |||||||||
| Total current liabilities | 1,255.0 | 1,595.7 | |||||||||
| Long-term debt | 1,121.6 | 814.2 | |||||||||
| Long-term operating lease liabilities | 162.5 | 161.8 | |||||||||
| Pensions | 33.9 | 40.1 | |||||||||
| Other liabilities | 157.6 | 158.9 | |||||||||
| Total liabilities | 2,730.6 | 2,770.7 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders' equity (deficit): | |||||||||||
| Preferred stock, $0.01 par value, 25,000,000 shares authorized, no shares issued or outstanding | — | — | |||||||||
| Common stock, $0.01 par value, 200,000,000 shares authorized, 87,170,197 shares issued | 0.9 | 0.9 | |||||||||
| Additional paid-in capital | 1,178.9 | 1,155.2 | |||||||||
| Retained earnings | 3,400.3 | 3,070.6 | |||||||||
| Accumulated other comprehensive loss | (77.0) | (90.6) | |||||||||
| Treasury stock, at cost, 51,633,264 shares and 51,700,260 shares for 2023 and 2022, respectively | (4,343.6) | (4,339.2) | |||||||||
| Total stockholders' equity (deficit) | 159.5 | (203.1) | |||||||||
| Total liabilities and stockholders' equity (deficit) | $ | 2,890.1 | $ | 2,567.6 |
The accompanying notes are an integral part of these consolidated financial statements.
LENNOX INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
| (Amounts in millions, except per share data) | For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Net sales | $ | 1,366.3 | $ | 1,244.9 | $ | 3,827.1 | $ | 3,624.6 | |||||||||||||||
| Cost of goods sold | 937.8 | 910.7 | 2,634.1 | 2,625.1 | |||||||||||||||||||
| Gross profit | 428.5 | 334.2 | 1,193.0 | 999.5 | |||||||||||||||||||
| Operating Expenses: | |||||||||||||||||||||||
| Selling, general and administrative expenses | 178.9 | 147.3 | 527.6 | 472.2 | |||||||||||||||||||
| Losses (gains) and other expenses, net | 3.5 | 3.3 | 5.2 | 5.4 | |||||||||||||||||||
| Restructuring charges | 0.3 | 0.2 | 0.2 | 1.2 | |||||||||||||||||||
| Impairment on assets held for sale | 63.2 | — | 63.2 | — | |||||||||||||||||||
| Income from equity method investments | (4.2) | (2.4) | (8.0) | (3.9) | |||||||||||||||||||
| Operating income | 186.8 | 185.8 | 604.8 | 524.6 | |||||||||||||||||||
| Pension settlements | 0.3 | — | 0.4 | 0.3 | |||||||||||||||||||
| Interest expense, net | 11.2 | 10.5 | 40.4 | 26.1 | |||||||||||||||||||
| Other expense (income), net | 0.1 | 0.7 | (0.1) | 1.9 | |||||||||||||||||||
| Net income before income taxes | 175.2 | 174.6 | 564.1 | 496.3 | |||||||||||||||||||
| Provision for income taxes | 44.8 | 32.7 | 118.5 | 93.6 | |||||||||||||||||||
| Net income | $ | 130.4 | $ | 141.9 | $ | 445.6 | $ | 402.7 | |||||||||||||||
| Earnings per share – Basic: | $ | 3.67 | $ | 4.00 | $ | 12.55 | $ | 11.25 | |||||||||||||||
| Earnings per share – Diluted: | $ | 3.65 | $ | 3.99 | $ | 12.51 | $ | 11.22 | |||||||||||||||
| Weighted Average Number of Shares Outstanding - Basic | 35.5 | 35.4 | 35.5 | 35.8 | |||||||||||||||||||
| **Weighted Average Number of Sh |
Showing the first 8K of 92K characters. Open the full section
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on information currently available to management as well as management’s assumptions and beliefs as of the date such statements were made. All statements, other than statements of historical fact, included in this Quarterly Report on Form 10-Q constitute forward-looking statements, including but not limited to statements identified by forward-looking terminology, such as the words “may,” “will,” “should,” “plan,” “anticipate,” “believe,” “intend,” “estimate” and “expect” and similar expressions. Such statements reflect our current views with respect to future events, based on what we believe are reasonable assumptions; however, such statements are subject to certain risks and uncertainties.
In addition to the specific uncertainties discussed elsewhere in this Quarterly Report on Form 10-Q, the risk factors set forth in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, and those set forth in Part II, “Item 1A. Risk Factors” of this report, if any, may affect our performance and results of operations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those in the forward-looking statements. We disclaim any intention or obligation to update or review any forward-looking statements or information, whether as a result of new information, future events or otherwise, except as required by law.
Business Overview
We operate in two reportable business segments of the heating, ventilation, air conditioning and refrigeration (“HVACR”) industry. Our reportable segments are Residential and Commercial. For additional information regarding our reportable segments, see Note 2 in the Notes to the Consolidated Financial Statements.
Our fiscal quarterly periods are comprised of approximately 13 weeks, but the number of days per quarter may vary year-over-year. Our quarterly reporting periods usually end on the Saturday closest to the last day of March, June and September. Our fourth quarter and fiscal year ends on December 31, regardless of the day of the week on which December 31 falls. For convenience, throughout this Management’s Discussion and Analysis of Financial Condition and Results of Operations, the 13-week periods comprising each fiscal quarter are denoted by the last day of the respective calendar quarter.
We sell our products and services through a combination of direct sales, distributors and company-owned parts and supplies stores. The demand for our products and services is seasonal and significantly impacted by the weather. Warmer than normal summer temperatures generate demand for replacement air conditioning and refrigeration products and services, and colder than normal winter temperatures have a similar effect on heating products and services. Conversely, cooler than normal summers and warmer than normal winters depress the demand for HVACR products and services. In addition to weather, demand for our products and services is influenced by national and regional economic and demographic factors, such as interest rates, the availability of financing, regional population and employment trends, new construction, general economic conditions, and consumer spending habits and confidence. A substantial portion of the sales in each of our business segments is attributable to replacement business, with the balance comprised of new construction business.
The principal elements of cost of goods sold are components, raw materials, factory overhead, labor, estimated warranty costs, and freight and distribution costs. The principal raw materials used in our manufacturing processes are steel, copper and aluminum. In recent years, pricing volatility for these commodities and related components, including the impact of imposed tariffs on the import of certain of our raw materials and components, has impacted us and the HVACR industry in general. We seek to mitigate the impact of volatility in commodity prices through a combination of price increases, commodity contracts, improved production efficiency and cost reduction initiatives. We also partially mitigate volatility in the prices of these commodities by entering into futures contracts and fixed forward contracts.
Change in Segment Reporting
Prior to January 1, 2023, we operated in three reportable business segments. In November 2022, we announced the decision to explore strategic alternatives for our European commercial HVAC and refrigeration businesses. We continue to operate and invest in our Heatcraft Worldwide Refrigeration business which became part of the Commercial segment effective on January 1, 2023, while the European portfolio will be presented with Corporate and Other until disposition. The consolidation of our Heatcraft business within the Commercial segment provides the opportunity to leverage synergies and create long-term growth opportunities by integrating entities with similar products, end consumers and financial performance metrics under the same management. The change in segment reporting better aligns with how the businesses are managed and evaluated given the change in portfolio. All amounts discussed in this Management's Discussion and Analysis of Financial Condition and Results of Operations reflect the revised segment presentation.
Financial Overview
Results for the third quarter of 2023 were driven by overall year-over-year sales and profit increases. Net sales increased 15% and segment profit increased $45 million for the Commercial segment. Net sales increased 7% and segment profit increased $28 million for the Residential segment. Net sales increased 13% and segment loss decreased $7 million for the Corporate & Other segment.
Financial Highlights
-
Net sales increased $121 million to $1,366 million in the third quarter of 2023 driven by favorable mix and price partially offset by lower sales volumes and unfavorable foreign currency.
-
Operating income in the third quarter of 2023 increased $1 million to $187 million primarily driven by favorable mix and price partially offset by a $63 million loss on assets held for sale.
-
Net income for the third quarter of 2023 was $130 million.
-
Diluted earnings per share was $3.65 per share in the third quarter of 2023 compared to $3.99 per share in the third quarter of 2022.
-
For the nine months ended September 30, 2023, we returned $153 million to shareholders through dividend payments.
Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022 - Consolidated Results
The following table provides a summary of our financial results, including information presented as a percentage of net sales:
| For the Three Months Ended September 30, | |||||||||||||||||||||||||||||
| Dollars (in millions) | Percent Change Fav/(Unfav) | Percent of Sales | |||||||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||
| Net sales | $ | 1,366.3 | $ | 1,244.9 | 9.8 | % | 100.0 | % | 100.0 | % | |||||||||||||||||||
| Cost of goods sold | 937.8 | 910.7 | (3.0) | 68.6 | 73.2 | ||||||||||||||||||||||||
| Gross profit | 428.5 | 334.2 | 28.2 | 31.4 | 26.8 | ||||||||||||||||||||||||
| Selling, general and administrative expenses | 178.9 | 147.3 | (21.5) | 13.1 | 11.8 | ||||||||||||||||||||||||
| Losses (gains) and other expenses, net | 3.5 | 3.3 | (6.1) | 0.3 | 0.3 | ||||||||||||||||||||||||
| Restructuring charges | 0.3 | 0.2 | (50.0) | — | — | ||||||||||||||||||||||||
| Impairment on assets held for sale | 63.2 | — | (100.0) | 4.6 | — | ||||||||||||||||||||||||
| Income from equity method investments | (4.2) | (2.4) | 75.0 | (0.3) | (0.2) | ||||||||||||||||||||||||
| Operating income | $ | 186.8 | $ | 185.8 | 0.5 | % | 13.7 | % | 14.9 | % |
Net Sales
Net sales for the third quarter of 2023 compared to the third quarter of 2022 increased 10% as a result of favorable mix of 6% and favorable product price of 5% which was partially offset by lower sales volumes of 1%.
Gross Profit
Gross profit margins in the third quarter of 2023 increased 460 basis points ("bps") to 31.4% compared to 26.8% in the third quarter of 2022. Gross margins increased 280 bps from favorable price, 220 bps from favorable product mix, and 70 bps from favorable commodity costs. Partially offsetting these increases were 40 bps from higher warranty costs, 30 bps from higher component costs, 20 bps from higher freight and distribution costs, 10 bps from lower sales volume, and 10 bps from higher other miscellaneous costs.
Selling, General and Administrative Expenses
Selling, general and administrative expenses ("SG&A") increased $32 million to $179 million in the third quarter of 2023 compared to $147 million in the third quarter of 2022 primarily due to higher employee-related costs including incentive compensation and wage inflation. As a percentage of net sales, SG&A increased 130 bps to 13.1%.
Losses (gains) and Other Expenses, Net
Losses (gains) and other expenses, net for the third quarter of 2023 and 2022 included the following (in millions):
| For the Three Months Ended September 30, | |||||||||||||||||||||||||||||
| 2023 | 2022 | ||||||||||||||||||||||||||||
| Realized losses on settled future contracts | $ | — | $ | 0.3 | |||||||||||||||||||||||||
| Foreign currency exchange (gains) losses | (1.2) | 0.3 | |||||||||||||||||||||||||||
| Gain on disposal of fixed assets | (0.2) | (0.4) | |||||||||||||||||||||||||||
| Other operating income | (0.1) | (0.2) | |||||||||||||||||||||||||||
| Environmental liabilities and special litigation charges | 3.9 | 3.1 | |||||||||||||||||||||||||||
| Other items, net | 1.1 | 0.2 | |||||||||||||||||||||||||||
| Losses (gains) and other expenses, net (pre-tax) | $ | 3.5 | $ | 3.3 |
Impairment on Assets Held for Sale
We recorded a $63 million impairment on assets held for sale in the third quarter of 2023 related to the sale of our European commercial HVAC and refrigeration businesses. The loss is the result of the difference between the expected fair value of the consideration received for these businesses, net of our costs to sell, and the carrying value of the net assets.
Income from Equity Method Investments
We participate in two joint ventures that are engaged in the manufacture and sale of compressors, unit coolers and condensing units. We exert significant influence over these affiliates based upon our ownership, but do not control them due to venture partner participation. Accordingly, these joint ventures have been accounted for under the equity method and their financial position and results of operations are not consolidated. We recognized income from equity method investments of $4 million in the third quarter of 2023 and $2 million in the third quarter of 2022.
Interest Expense, net
Interest expense, net remained relatively unchanged at $11 million in the third quarter of 2023 as compared to the third quarter of 2022.
Income Taxes
Our effective tax rate was 25.6% for the third quarter of 2023 compared to 18.7% for the third quarter of 2022. The rate increased primarily due to the allocation of income to higher tax jurisdictions and a discrete adjustment related to the European businesses.
We expect our annual effective tax rate to be 20-22%, excluding the impacts of excess tax benefits recorded as a reduction of income taxes under ASU No. 2016-09.
Third Quarter of 2023 Compared to Third Quarter of 2022 - Results by Segment
Residential
The following table presents our Residential segment's net sales and profit for the third quarter of 2023 and 2022 (dollars in millions):
| For the Three Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 896.3 | $ | 835.3 | $ | 61.0 | 7 | % | |||||||||||||||
| Profit | $ | 181.4 | $ | 153.8 | $ | 27.6 | 18 | % | |||||||||||||||
| % of net sales | 20.2 | % | 18.4 | % |
Net sales increased 7% in the third quarter of 2023 compared to 2022 due to favorable product mix of 7% and higher price of 2%. Partially offsetting these increases were lower sales volumes of 2%.
Segment profit in the third quarter of 2023 compared to 2022 increased by $28 million, primarily due to $37 million from favorable product mix, $14 million from higher price and $10 million from lower commodity costs. Partially offsetting these increases were $16 million from higher SG&A costs, $7 million from higher factory inefficiencies, $6 million from miscellaneous other items and $4 million from lower sales volumes.
Commercial
The following table presents our Commercial segment's net sales and profit for the third quarter of 2023 and 2022 (dollars in millions):
| For the Three Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 (1) | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 405.5 | $ | 352.3 | $ | 53.2 | 15 | % | |||||||||||||||
| Profit | $ | 97.3 | $ | 52.4 | $ | 44.9 | 86 | % | |||||||||||||||
| % of net sales | 24.0 | % | 14.9 | % |
(1) 2022 amounts have been recast to reflect the changes in segment reporting. Please see Note 2 in the Notes to the Consolidated Financial Statements for further detail.
Net sales increased 15% in the third quarter of 2023 compared to 2022 as price increased 10%, product mix increased 3% and sales volumes increased 2%.
Segment profit in the third quarter of 2023 compared to 2022 increased $45 million primarily due to $37 million from favorable price, $10 million from favorable product mix, and $1 million from higher sales volumes. Partially offsetting these increases were $3 million from higher SG&A costs.
Corporate and Other
The following table presents our Corporate and Other segment's net sales and loss for the third quarter of 2023 and 2022 (dollars in millions):
| For the Three Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 (1) | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 64.5 | $ | 57.3 | $ | 7.2 | 13 | % | |||||||||||||||
| Loss | $ | (23.4) | $ | (16.9) | $ | (6.5) | (38) | % | |||||||||||||||
(1) 2022 amounts have been recast to reflect the changes in segment reporting. Please see Note 2 in the Notes to the Consolidated Financial Statements for further detail.
Net sales increased $7 million and segment loss increased $7 million in the third quarter of 2023 as compared to 2022. Our European businesses generated $4 million profit in the third quarter of 2023 and a loss of less than $1 million in the third quarter of 2022. Excluding our European businesses, Corporate and Other costs increased to $11 million in the third quarter of 2023 compared to 2022 due primarily to higher incentive compensation and wage inflation.
Year-to-Date through September 30, 2023 Compared to Year-to-Date through September 30, 2022 - Consolidated Results
The following table provides a summary of our financial results, including information presented as a percentage of net sales:
| For the Nine Months Ended September 30, | |||||||||||||||||||||||||||||
| Dollars (in millions) | Percent Change Fav/(Unfav) | Percent of Sales | |||||||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||
| Net sales | $ | 3,827.1 | $ | 3,624.6 | 5.6 | % | 100.0 | % | 100.0 | % | |||||||||||||||||||
| Cost of goods sold | 2,634.1 | 2,625.1 | (0.3) | 68.8 | 72.4 | ||||||||||||||||||||||||
| Gross profit | 1,193.0 | 999.5 | 19.4 | 31.2 | 27.6 | ||||||||||||||||||||||||
| Selling, general and administrative expenses | 527.6 | 472.2 | (11.7) | 13.8 | 13.0 | ||||||||||||||||||||||||
| Losses (gains) and other expenses, net | 5.2 | 5.4 | 3.7 | 0.1 | 0.1 | ||||||||||||||||||||||||
| Restructuring charges | 0.2 | 1.2 | 83.3 | — | — | ||||||||||||||||||||||||
| Impairment on assets held for sale | 63.2 | — | (100.0) | 1.7 | — | ||||||||||||||||||||||||
| Income from equity method investments | (8.0) | (3.9) | 105.1 | (0.2) | (0.1) | ||||||||||||||||||||||||
| Operating income | $ | 604.8 | $ | 524.6 | 15.3 | % | 15.8 | % | 14.5 | % |
Net Sales
Net sales increased 6% for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 due to favorable product mix of 6% and higher price of 5%. Partially offsetting these increases were lower sales volumes of 5%.
Gross Profit
Gross profit margins for the nine months ended September 30, 2023 increased 360 bps to 31.2% compared to 27.6% for the nine months ended September 30, 2022. Gross margins increased 350 bps from higher price, 140 bps from favorable mix and 90 bps from lower commodity costs. Partially offsetting these increases were 70 bps from higher other product costs, 60 bps from higher component costs, 40 bps from lower sales volumes, 30 bps from higher freight and distribution costs and 20 bps from higher miscellaneous other costs.
Selling, General and Administrative Expenses
SG&A increased $55 million to $528 million for the nine months ended September 30, 2023 compared to $472 million for
the nine months ended September 30, 2022 primarily due to higher employee-related costs. As a percentage of net sales, SG&A increased 80 bps to 13.8% from 13.0%.
Losses (gains) and Other Expenses, Net
Losses (gains) and other expenses, net for the nine months ended September 30, 2023 and 2022 included the following (in millions):
| For the Nine Months Ended September 30, | |||||||||||||||||||||||||||||
| 2023 | 2022 | ||||||||||||||||||||||||||||
| Realized losses (gains) on settled future contracts | $ | 0.1 | $ | (0.1) | |||||||||||||||||||||||||
| Foreign currency exchange gains | (4.2) | (0.5) | |||||||||||||||||||||||||||
| Gain on disposal of fixed assets | (1.4) | (1.3) | |||||||||||||||||||||||||||
| Other operating income | (1.4) | (0.6) | |||||||||||||||||||||||||||
| Net change in unrealized (gains) losses on unsettled futures contracts | (0.1) | 1.2 | |||||||||||||||||||||||||||
| Environmental liabilities and special litigation charges | 11.1 | 6.2 | |||||||||||||||||||||||||||
| Other items, net | 1.1 | 0.5 | |||||||||||||||||||||||||||
| Losses (gains) and other expenses, net (pre-tax) | $ | 5.2 | $ | 5.4 |
Impairment on Assets Held for Sale
We recorded a $63 million impairment on assets held for sale in the third quarter of 2023 related to the sale of our European commercial HVAC and refrigeration businesses. The loss is the result of the difference between the expected fair value of the consideration received for these businesses, net of our costs to sell, and the carrying value of the net assets.
Income from Equity Method Investments
Income from equity method investments increased to $8 million for the nine months ended September 30, 2023 as compared to $4 million for the nine months ended September 30, 2022. The increase was due to lower operating costs at the investments.
Interest Expense, net
Interest expense, net increased $14 million for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 primarily due to higher interest rates.
Income Taxes
Our effective tax rate increased to 21.0% for the nine months ended September 30, 2023 compared to 18.9% for the nine months ended September 30, 2022 primarily due to the allocation of income to higher tax jurisdictions and a discrete adjustment related to the European divestiture.
Year-to-Date through September 30, 2023 Compared to Year-to-Date through September 30, 2022 - Results by Segment
Residential
The following table presents our Residential segment's net sales and profit for the nine months ended September 30, 2023 and 2022 (dollars in millions):
| For the Nine Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 2,513.6 | $ | 2,494.9 | $ | 18.7 | 1 | % | |||||||||||||||
| Profit | $ | 495.2 | $ | 477.7 | $ | 17.5 | 4 | % | |||||||||||||||
| % of net sales | 19.7 | % | 19.1 | % |
Net sales increased 1% for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 due to favorable product mix of 7% and higher price of 2%. Partially offsetting these increases was lower sales volumes of 8%.
Segment profit for the first nine months of 2023 compared to 2022 increased $17 million primarily due to $65 million from favorable product mix, $60 million from higher price, and $27 million from lower commodity costs. Partially offsetting these increases was $62 million from lower sales volumes, $34 million from higher SG&A costs, $17 million from higher freight and distribution costs, $13 million from higher component costs, and $9 million from miscellaneous other items.
Commercial
The following table presents our Commercial segment's net sales and profit for the nine months ended September 30, 2023 and 2022 (dollars in millions):
| For the Nine Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 (1) | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 1,121.5 | $ | 959.2 | $ | 162.3 | 17 | % | |||||||||||||||
| Profit | $ | 250.3 | $ | 117.4 | $ | 132.9 | 113 | % | |||||||||||||||
| % of net sales | 22.3 | % | 12.2 | % |
(1) 2022 amounts have been recast to reflect the changes in segment reporting. Please see Note 2 in the Notes to the Consolidated Financial Statements for further detail.
Net sales increased 17% for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 as price increased 11% and product mix was 6% favorable.
Segment profit for the first nine months of 2023 compared to 2022 increased $133 million primarily due to $112 million from higher price, $43 million from favorable product mix, $6 million from lower commodity costs, and $6 million from lower freight and distribution costs. Partially offsetting these increases were $16 million from higher other product costs including warranty costs, $9 million from higher component costs, and $9 million from higher SG&A costs.
Corporate and Other
The following table presents our Corporate and Other segment's net sales and loss for the nine months ended September 30, 2023 and 2022 (dollars in millions):
| For the Nine Months Ended September 30, | |||||||||||||||||||||||
| 2023 | 2022 (1) | Difference | % Change | ||||||||||||||||||||
| Net sales | $ | 192.0 | $ | 170.5 | $ | 21.5 | 13 | % | |||||||||||||||
| Loss | $ | (65.2) | $ | (61.4) | $ | (3.8) | (6) | % | |||||||||||||||
(1) 2022 amounts have been recast to reflect the changes in segment reporting. Please see Note 2 in the Notes to the Consolidated Financial Statements for further detail.
Net sales increased $21 million and segment loss increased $4 million during the nine months ended September 30, 2023 as compared to 2022. Our European businesses generated a profit of $6 million in the nine months ended September 30, 2023 and a loss of $4 million in the nine months ended September 30, 2022. Excluding our European businesses, Corporate and Other costs increased $14 million due primarily to higher incentive compensation costs and wage inflation.
Liquidity and Capital Resources
Our working capital and capital expenditure requirements are generally met through internally generated funds, bank lines of credit and an asset securitization arrangement. Upon expiration of the asset securitization arrangement, our new commercial
paper program (described below) will serve as an additional source of liquidity. Working capital needs are generally greater in the first and second quarters due to the seasonal nature of our business cycle.
Statement of Cash Flows
The following table summarizes our cash flow activity for the nine months ended September 30, 2023 and 2022 (in millions):
| For the Nine Months Ended September 30, | |||||||||||
| 2023 | 2022 | ||||||||||
| Net cash provided by operating activities | $ | 429.9 | $ | 170.1 | |||||||
| Net cash used in investing activities | (124.5) | (68.2) | |||||||||
| Net cash used in financing activities | (215.6) | (89.1) |
Net Cash Provided By Operating Activities - The change in net cash provided by operating activities for the nine months ended September 30, 2023 compared to the net cash provided by operating activities for the same period in 2022 reflects changes in working capital and an increase in net income.
Net Cash Used In Investing Activities - Capital expenditures were $125 million for the nine months ended September 30, 2023 compared to $67 million in the same period of 2022. Capital expenditures in 2023 were related to our Commercial factory in Mexico, the general expansion of manufacturing capacity and equipment, and investments in systems and software to support the overall enterprise.
Net Cash Used In Financing Activities - Net cash used in financing activities for the nine months ended September 30, 2023 increased to $216 million compared to $89 million used in financing activities in the same period of 2022. The change was primarily due to changes net borrowings and repayments of long-term debt partially offset by less share repurchases. We did not repurchase any shares for the nine months ended September 30, 2023 and we repurchased $300 million in shares in the same period of 2022. We returned $153 million to shareholders through dividend payments for the nine months ended September 30, 2023 and $142 million in the same period of 2022. For additional information on share repurchases, refer to Note 5 in the Notes to the Consolidated Financial Statements.
Debt Position
The following table details our lines of credit and financing arrangements as of September 30, 2023 (in millions):
| Outstanding Borrowings | |||||
| Current maturities of long-term debt: | |||||
| Asset securitization program (1) | $ | — | |||
| Finance lease obligations | 11.6 | ||||
| Senior unsecured notes | 350.0 | ||||
| Debt issuance costs | — | ||||
| Total current maturities of long-term debt | $ | 361.6 | |||
| Long-term debt: | |||||
| Finance lease obligations | 31.9 | ||||
| Credit agreement (2) | — | ||||
| Senior unsecured notes | 1,100.0 | ||||
| Debt issuance costs | (10.3) | ||||
| Total long-term debt | 1,121.6 | ||||
| Total debt | $ | 1,483.2 |
(1) The maximum securitization amount ranges from $300.0 million to $450.0 million, depending on the period. The maximum capacity of the ASP is the lesser of the maximum securitization amount or 100% of the net pool balance less reserves, as defined under the ASP. Refer to Note 11 in the Notes to the Consolidated Financial Statements for more information.
(2) The available future borrowings on our Credit Agreement (as defined below) are $1,098.3 million, after being reduced by the outstanding borrowings and $1.7 million in outstanding standby letters of credit. Refer to Note 11 in the Notes to the Consolidated Financial Statements for more information.
Second Amendment to the Credit Agreement
In August 2023, we entered into the Second Amendment (the “Second Amendment”) to the Credit Agreement, dated as of July 14, 2021 (as amended, the "Credit Agreement"), with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto. Under the Second Amendment, the revolving commitments were increased by $350 million and certain representations required to be made as conditions precedent to borrowing were revised to provide us greater flexibility to enter into additional future financing.
The Credit Agreement provides for revolving credit commitments of $1.1 billion with sublimits for swingline loans of up to $65 million, letters of credit up to $100 million and revolving loans in certain non-U.S. currencies up to the U.S. dollar equivalent of $40 million. The Credit Agreement will expire and outstanding loans will be required to be repaid in July 2026, unless maturity is extended by the lenders pursuant to two one-year extension options that we may request under the Credit Agreement.
The Credit Agreement is guaranteed by certain of our subsidiaries and contains customary covenants applicable to us and our subsidiaries including limitations on indebtedness, liens, dividends, stock repurchases, mergers and sales of all or substantially all of our assets. In addition, the Credit Agreement contains a financial covenant requiring us to maintain, as of the last day of each fiscal quarter for the four prior fiscal quarters, a Total Net Leverage Ratio of no more than 3.50 to 1.00 (or, at our election, on up to two occasions following a material acquisition, 4.00 to 1.00). The Credit Agreement is subject to customary events of default, including non-payment of principal or other amounts under the Credit Agreement, material inaccuracy of representations and warranties, breach of covenants, cross-default to other indebtedness in excess of $75 million, judgements in excess of $75 million, certain voluntary and involuntary bankruptcy events, and the occurrence of a change of control. As of September 30, 2023, we believe we were in compliance with all covenant requirements.
Senior Unsecured Notes
In September 2023, we issued $500.0 million of senior unsecured notes, which will mature in September 2028 (the "2028 Notes") with interest being paid semi-annually in March and September at 5.50%. We issued two series of senior unsecured notes on July 30, 2020 for $300.0 million each, which will mature on August 1, 2025 (the "2025 Notes") and August 1, 2027 (the "2027 Notes") with interest being paid semi-annually in February and August at 1.35% and 1.70% respectively, per annum. We also issued $350.0 million of senior unsecured notes in November 2016 (the "2023 Notes," and together with the 2025 Notes, 2027 Notes, and the 2028 Notes, the "Notes") which will mature on November 15, 2023 with interest being paid semi-annually on May 15 and November 15 at 3.00% per annum.
All the Notes are guaranteed, on a senior unsecured basis, by certain of our subsidiaries that guarantee indebtedness under our Credit Agreement. The indenture governing the Notes contains covenants that, among other things, limit our ability and the ability of the subsidiary guarantors to: create or incur certain liens; enter into certain sale and leaseback transactions; and enter into certain mergers, consolidations and transfers of substantially all of our assets. The indenture also contains a cross default provision which is triggered if we default on other debt of at least $75.0 million in principal which is then accelerated, and such acceleration is not rescinded within 30 days of the notice date. As of September 30, 2023, we believe we were in compliance with all covenant requirements.
Financial Leverage
We periodically review our capital structure to ensure the appropriate levels of leverage and liquidity. We may access the capital markets, as necessary, based on business needs and to take advantage of favorable interest rate environments or other market conditions. We also evaluate our debt-to-capital and debt-to-EBITDA ratios to determine, among other considerations, the appropriate targets for capital expenditures and share repurchases under our share repurchase programs. Our debt-to-total-capital ratio decreased to 90% at September 30, 2023 from 115% at December 31, 2022.
As of September 30, 2023, our senior credit ratings were Baa2 with a stable outlook, and BBB with a stable outlook, by Moody's Investors Service, Inc. ("Moody's") and Standard & Poor's Rating Group ("S&P"), respectively. The security ratings are not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time by the assigning rating agency. Each rating should be evaluated independently of any other rating. Our goal is to maintain investment grade ratings from Moody's and S&P to help ensure the capital markets remain available to us.
Liquidity
We believe our cash and cash equivalents of $132 million, future cash generated from operations and available borrowing capacity are sufficient to fund operations, planned capital expenditures, future contractual obligations, potential share repurchases and dividends and other needs in the foreseeable future. Included in our cash and cash equivalents of $132 million as of September 30, 2023 was $18 million of cash held in foreign locations. Our cash held in foreign locations is used for investing and operating activities in those locations, and we generally do not have the need or intent to repatriate those funds to the United States. An actual repatriation in the future from our non-U.S. subsidiaries could be subject to foreign withholding taxes and U.S. state taxes.
Both our ASP as well as our $350.0 million 2023 Notes will mature during the fourth quarter. We pre-funded the 2023 notes maturity through the issuance of the 2028 Notes. We are replacing the expiring ASP with a $500.0 million commercial paper program, as described below. We do not believe that these changes will have any material impact on our results of operation or liquidity.
Guarantees related to our Debt Obligations
Our senior unsecured notes were issued by Lennox International Inc. and are unconditionally guaranteed by certain of our subsidiaries (the "Guarantor Subsidiaries"). The Guarantor Subsidiaries are 100% owned and consolidated, all guarantees are full and unconditional, and all guarantees are joint and several.
The following combined Parent and Guarantor Subsidiaries financial information is presented as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 (in millions):
| September 30, 2023 | December 31, 2022 | ||||||||||
| Current assets | 933.7 | 772.1 | |||||||||
| Non-current assets | 6,086.7 | 4,844.4 | |||||||||
| Current liabilities | 1,004.9 | 1,023.2 | |||||||||
| Non-current liabilities | 1,456.2 | 1,149.0 | |||||||||
| Amounts due to non-guarantor subsidiaries | (725.4) | (537.7) |
| For the Three Months Ended September 30, 2023 | For the Nine Months Ended, September 30, 2023 | ||||||||||
| Net Sales | 1,289.0 | 3,559.3 | |||||||||
| Gross Profit | 339.5 | 888.4 | |||||||||
| Net Income | 372.2 | 1,072.6 |
Off Balance Sheet Arrangements
An off-balance sheet arrangement is any transaction, agreement or other contractual arrangement involving an unconsolidated entity under which the company has: (1) made guarantees, (2) a retained or a contingent interest in transferred assets, (3) an obligation under derivative instruments classified as equity or (4) any obligation arising out of a material variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us, or that engages in leasing, hedging or research and development arrangements with us. We have no off-balance sheet arrangements that we believe may have a material current or future effect on our financial condition, liquidity or results of operations.
Commitments, Contingencies and Guarantees
For information regarding our commitments, contingencies and guarantees, see Note 4 in the Notes to the Consolidated Financial Statements.
Recent Accounting Pronouncements
There were no recent accounting pronouncements that are expected to have a material impact on our financial statements and disclosures.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For quantitative and qualitative disclosures about market risk affecting LII, see "Quantitative and Qualitative Disclosures About Market Risk" in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. Our exposure to market risk has not changed materially since December 31, 2022.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
As required by Rule 13a-15 under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our current management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2023, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II - Other Information
Item 1. Legal Proceedings
We are involved in a number of claims and lawsuits incidental to the operation of our businesses. Where appropriate, insurance coverages are maintained and estimated costs are recorded for such claims and lawsuits. It is management's opinion that none of these claims or lawsuits will have a material adverse effect, individually or in the aggregate, on our financial position, results of operations or cash flows.
Item 1A. Risk Factors
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, which could materially affect our business, financial condition or results of operations. There have been no material changes to our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
We did not repurchase any shares of our common stock in the third quarter of 2023. For additional information on our share repurchase program, refer to Note 5 in the Notes to the Consolidated Financial Statements.
Item 5. Other Information
Rule 10b5-1 Plan Elections
During the quarter ended September 30, 2023, none of our directors or officers adopted, modified, or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408(a) of Regulation S-K.
Commercial Paper Program
The information set forth below in this Item 5 is included herein in lieu of reporting on a Current Report on Form 8-K under Item 2.03. Creation of a Direct Financial Obligation of a Registrant.
On October 25, 2023, we established a commercial paper program (the “Program”) pursuant to which we may issue short-term, unsecured commercial paper notes (the “CP Notes”) under the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). Amounts available under the Program may be borrowed, repaid, and re-borrowed from time to time, with the aggregate face or principal amount of the CP Notes outstanding under the Program at any time not to exceed $500.0 million. The CP Notes will have maturities of up to 397 days from the date of issue. The CP Notes will rank pari passu with all of our other unsecured and unsubordinated indebtedness. The net proceeds of the issuances of the CP Notes are expected to be used for general corporate purposes. We plan to use our revolving credit facility as a liquidity backstop for the repayment of CP Notes outstanding under the Program. No CP Notes are currently outstanding under the Program.
One or more commercial paper dealers will each act as a dealer under the Program (each, a “Dealer,” and collectively, the “Dealers”) pursuant to the terms and conditions of the respective commercial paper dealer agreement entered into between us and each Dealer (each, a “Dealer Agreement,” and collectively, the “Dealer Agreements”). We may engage additional commercial paper dealers to act as dealers under the Program. A national bank will act as the issuing and paying agent under the Program pursuant to the terms of an issuing and paying agent agreement.
The Dealer Agreements provide the terms under which the Dealers will either purchase from us or arrange for the sale of the CP Notes by us. The Dealer Agreements contain customary representations, warranties, covenants, and indemnification provisions.
From time to time, the Dealers and certain of their respective affiliates have provided, and may in the future provide, lending, commercial banking, investment banking and other financial advisory services to us and our affiliates for which such Dealers have received or will receive customary fees and expenses.
The CP Notes have not been and will not be registered under the Securities Act or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. The information contained in this Quarterly Report on Form 10-Q is neither an offer to sell nor a solicitation of an offer to buy any CP Notes.
Item 6. Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LENNOX INTERNATIONAL INC.
By: /s/ Joseph W. Reitmeier
Joseph W. Reitmeier
Chief Financial Officer
(on behalf of registrant and as principal financial officer)
Date: October 26, 2023